David C. Hastings
2010 - Incyte
In 2010, David C. Hastings earned a total compensation of $1M as Executive Vice President and Chief Financial Officer at Incyte, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,101 |
|---|---|
| Option Awards | $483,440 |
| Salary | $323,638 |
| Other | $3,493 |
| Total | $1,011,672 |
Hastings received $483.4K in option awards, accounting for 48% of the total pay in 2010.
Hastings also received $201.1K in non-equity incentive plan, $323.6K in salary and $3.5K in other compensation.
Rankings
In 2010, David C. Hastings' compensation ranked 5,270th out of 10,439 executives tracked by ExecPay. In other words, Hastings earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,270 out of 10,439 | 50th |
Division Services | 775 out of 1,534 | 50th |
Major group Engineering, Accounting, Research, Management, And Related Services | 69 out of 166 | 58th |
Industry group Research, Development, And Testing Services | 16 out of 46 | 65th |
Industry Commercial Physical and Biological Research | 16 out of 43 | 63rd |
Source: SEC filing on April 18, 2013.
Hastings' colleagues
We found five more compensation records of executives who worked with David C. Hastings at Incyte in 2010.
2010
Paul Friedman
Incyte
Chief Executive Officer
2010
Patricia Andrews
Incyte
Executive Vice President and Chief Commercial Officer
2010
Brian Metcalf
Incyte
Executive Vice President and Chief Drug Discovery Scientist
2010
Richard Levy
Incyte
Executive Vice President, Chief Drug Development and Medical Officer
2010
Paula Swain
Incyte